Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Velicept presents positive topline results from VEL-2002 study of solabegron

March 29, 2019

Phase III PATENCY-2 trial of vonapanitase does not meet its coprimary endpoints

March 29, 2019

Tricida reports results from extension trial of TRC-101 in CKD patients with metabolic acidosis

March 28, 2019

Urovant Sciences launches international phase III COURAGE study of vibegron

March 28, 2019

New mutations in NPHP3 and NEK8 are associated with renal-hepatic-pancreatic dysplasia

March 26, 2019

Positive topline results presented from pivotal phase III EMPOWUR study of vibegron

March 20, 2019

Arch Biopartners receives approval for phase I study of Metablok in Australia

March 20, 2019

Clinical data reported for litoxetine in mixed urinary incontinence

March 19, 2019

Veverimer phase III results for metabolic acidosis associated with chronic kidney disease

March 15, 2019

Dicerna enrolling in phase II study of DCR-PHXC for primary hyperoxaluria

March 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...